- Home
- PMEC vs ALGS Comparison
PMEC vs ALGS Comparison
Compare PMEC & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMEC | ALGS |
|---|---|---|
| Founded | 1984 | 2018 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 57.2M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PMEC | ALGS |
|---|---|---|
| Price | $1.08 | $9.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | ★ 193.2K | 76.5K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $74,349,000.00 | $2,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.52 | N/A |
| 52 Week Low | $0.54 | $3.76 |
| 52 Week High | $2.44 | $46.80 |
Technical Indicators
Market Signals| Indicator | PMEC | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 62.82 |
| Support Level | $0.97 | $9.10 |
| Resistance Level | $1.10 | $10.45 |
| Average True Range (ATR) | 0.09 | 0.69 |
| MACD | 0.03 | 0.25 |
| Stochastic Oscillator | 58.54 | 87.93 |
Price Performance
Historical ComparisonAbout PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.